Abstract
Renovascular hypertension is a potentially curable form of secondary hypertension generally due to either atherosclerosis or fibromuscular dysplasia of one or both renal arteries.1,2 The critical element promoting hypertension in this disorder is reduced arterial perfusion to one or both kidneys,1 leading to increased production of renin, which elevates circulating angiotensin II levels.1,2 The resultant high-renin hypertensive state is associated with moderate-to-severe elevation of blood pressure, with an attendant high risk of cardiovascular disease and progressive loss of renal function in the flow-deprived kidney.1 Treatment of renovascular hypertension with angioplasty, stenting, or surgery affords an opportunity to reduce . . .